Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Coelho Santos, Vanessa ^a   Gonçalves, Joana ^a   Fontes Ribeiro, Carlos ^a   Silva, Ana P ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Apoptosis; Interleukine 6; JAK STAT3; Methamphetamine; Microglia; Tumor necrosis factor alpha

Indexed keywords

BROXURIDINE; DNA NUCLEOTIDYLEXOTRANSFERASE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ALPHA; JANUS KINASE; METHAMPHETAMINE; PROTEIN BAX; PROTEIN BCL 2; STAT3 PROTEIN; TRANSCRIPTION FACTOR 3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOUSE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84861468888     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-103     Document Type: Article

References (66)

1. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004, 24:6028-6036. 10.1523/JNEUROSCI.0713-04.2004, 15229250.
2. McCann UD, Kuwabara H, Kumar A, Palermo M, Abbey R, Brasic J, Ye W, Alexander M, Dannals RF, Wong DF, Ricaurte GA. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 2008, 62:91-100. 10.1002/syn.20471, 17992686.
3. Sekine Y, Ouchi Y, Sugihara G, Takei N, Yoshikawa E, Nakamura K, Iwata Y, Tsuchiya KJ, Suda S, Suzuki K, Kawai M, Takebayashi K, Yamamoto S, Matsuzaki H, Ueki T, Mori N, Gold MS, Cadet JL. Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 2008, 28:5756-5761. 10.1523/JNEUROSCI.1179-08.2008, 2491906, 18509037.
4. Pubill D, Canudas AM, Pallas M, Camins A, Camarasa J, Escubedo E. Different glial response to methamphetamine-and methylenedioxymethamphetamine-induced neurotoxicity. Naunyn Schmiedebergs Arch Pharmacol 2003, 367:490-499. 10.1007/s00210-003-0747-y, 12684743.
5. Wu CW, Ping YH, Yen JC, Chang CY, Wang SF, Yeh CL, Chi CW, Lee HC. Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis. Toxicol Appl Pharmacol 2007, 220:243-251. 10.1016/j.taap.2007.01.011, 17350664.
6. Rocher C, Gardier AM. Effects of repeated systemic administration of d-Fenfluramine on serotonin and glutamate release in rat ventral hippocampus: comparison with methamphetamine usingin vivomicrodialysis. Naunyn Schmiedebergs Arch Pharmacol 2001, 363:422-428. 10.1007/s002100000381, 11330336.
7. Stephans SE, Yamamoto BK. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 1994, 17:203-209. 10.1002/syn.890170310, 7974204.
8. Brown JM, Quinton MS, Yamamoto BK. Methamphetamine-induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite. J Neurochem 2005, 95:429-436. 10.1111/j.1471-4159.2005.03379.x, 16086684.
9. Gonçalves J, Baptista S, Martins T, Milhazes N, Borges F, Ribeiro CF, Malva JO, Silva AP. Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur J Neurosci 2010, 31:315-326. 10.1111/j.1460-9568.2009.07059.x, 20074221.
10. LaVoie MJ, Card JP, Hastings TG. Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp Neurol 2004, 187:47-57. 10.1016/j.expneurol.2004.01.010, 15081587.
11. Goncalves J, Martins T, Ferreira R, Milhazes N, Borges F, Ribeiro CF, Malva JO, Macedo TR, Silva AP. Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain. Ann N Y Acad Sci 2008, 1139:103-111. 10.1196/annals.1432.043, 18991854.
12. Thomas DM, Walker PD, Benjamins JA, Geddes TJ, Kuhn DM. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther 2004, 311:1-7. 10.1124/jpet.104.070961, 15163680.
13. Sriram K, Miller DB, O'Callaghan JP. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem 2006, 96:706-718. 10.1111/j.1471-4159.2005.03566.x, 16405514.
14. Thomas DM, Francescutti-Verbeem DM, Kuhn DM. Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling. J Neurochem 2008, 106:696-705. 10.1111/j.1471-4159.2008.05421.x, 2668116, 18410508.
15. Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Prog Neurobiol 1999, 57:563-581. 10.1016/S0301-0082(98)00069-0, 10221782.
16. Bernardino L, Malva JO. Inflammation and neuronal susceptibility to excitotoxic cell death. Interaction Between Neurons and Glia in Aging and Disease 2007, 3-35. Springer US, New York, Malva JO, Rego AC, Cunha RA, Oliveira CR.
17. Vilcek J, Feldmann M. Historical review: cytokines as therapeutics and targets of therapeutics. Trends Pharmacol Sci 2004, 25:201-209. 10.1016/j.tips.2004.02.011, 15063084.
18. Leonard M, Ryan MP, Watson AJ, Schramek H, Healy E. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells. Kidney Int 1999, 56:1366-1377. 10.1046/j.1523-1755.1999.00664.x, 10504489.
19. Amrani Y, Ammit AJ, Panettieri RA. Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells: role of p38 and p42/44 mitogen-activated protein kinases. Mol Pharmacol 2001, 60:646-655.
20. Kinouchi K, Brown G, Pasternak G, Donner DB. Identification and characterization of receptors for tumor necrosis factor-alpha in the brain. Biochem Biophys Res Commun 1991, 181:1532-1538. 10.1016/0006-291X(91)92113-X, 1662500.
21. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001, 11:372-377. 10.1016/S0962-8924(01)02064-5, 11514191.
22. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003, 374:1-20. 10.1042/BJ20030407, 1223585, 12773095.
23. Sparacio SM, Zhang Y, Vilcek J, Benveniste EN. Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein. J Neuroimmunol 1992, 39:231-242. 10.1016/0165-5728(92)90257-L, 1644898.
24. Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J 1996, 15:1914-1923. 450110, 8617238.
25. Penkowa M, Giralt M, Carrasco J, Hadberg H, Hidalgo J. Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia 2000, 32:271-285. 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5, 11102968.
26. Pizzi M, Sarnico I, Boroni F, Benarese M, Dreano M, Garotta G, Valerio A, Spano P. Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices. Mol Cell Neurosci 2004, 25:301-311. 10.1016/j.mcn.2003.10.022, 15019946.
27. Hakkoum D, Stoppini L, Muller D. Interleukin-6 promotes sprouting and functional recovery in lesioned organotypic hippocampal slice cultures. J Neurochem 2007, 100:747-757. 10.1111/j.1471-4159.2006.04257.x, 17144903.
28. Islam O, Gong X, Rose-John S, Heese K. Interleukin-6 and neural stem cells: more than gliogenesis. Mol Biol Cell 2009, 20:188-199. 10.1091/mbc.E08-05-0463, 2613125, 18971377.
29. Quintanilla RA, Orellana DI, Gonzalez-Billault C, Maccioni RB. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp Cell Res 2004, 295:245-257. 10.1016/j.yexcr.2004.01.002, 15051507.
30. Pavelko KD, Howe CL, Drescher KM, Gamez JD, Johnson AJ, Wei T, Ransohoff RM, Rodriguez M. Interleukin-6 protects anterior horn neurons from lethal virus-induced injury. J Neurosci 2003, 23:481-492.
31. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 2011, 1813:878-888. 10.1016/j.bbamcr.2011.01.034, 21296109.
32. Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Yamanishi K, Taga T, Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 1993, 260:1808-1810. 10.1126/science.8511589, 8511589.
33. Ihle JN. STATs: signal transducers and activators of transcription. Cell 1996, 84:331-334. 10.1016/S0092-8674(00)81277-5, 8608586.
34. Jenab S, Quinones-Jenab V. The effects of interleukin-6, leukemia inhibitory factor and interferon-gamma on STAT DNA binding and c-fos mRNA levels in cortical astrocytes and C6 glioma cells. Neuro Endocrinol Lett 2002, 23:325-328.
35. Sanz E, Hofer MJ, Unzeta M, Campbell IL. Minimal role for STAT1 in interleukin-6 signaling and actions in the murine brain. Glia 2008, 56:190-199. 10.1002/glia.20602, 18023015.
36. Ladenheim B, Krasnova IN, Deng X, Oyler JM, Polettini A, Moran TH, Huestis MA, Cadet JL. Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol Pharmacol 2000, 58:1247-1256.
37. Tocharus J, Khonthun C, Chongthammakun S, Govitrapong P. Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines. J Pineal Res 2010, 48:347-352. 10.1111/j.1600-079X.2010.00761.x, 20374443.
38. Righi M, Mori L, De Libero G, Sironi M, Biondi A, Mantovani A, Donini SD, Ricciardi-Castagnoli P. Monokine production by microglial cell clones. Eur J Immunol 1989, 19:1443-1448. 10.1002/eji.1830190815, 2789141.
39. Aizenman E, McCord MC, Saadi RA, Hartnett KA, He K. Complex role of zinc in methamphetamine toxicityin vitro. Neuroscience 2010, 171:31-39. 10.1016/j.neuroscience.2010.08.049, 2956874, 20801194.
40. Nopparat C, Porter JE, Ebadi M, Govitrapong P. The mechanism for the neuroprotective effect of melatonin against methamphetamine-induced autophagy. J Pineal Res 2010, 49:382-389. 10.1111/j.1600-079X.2010.00805.x, 20738755.
41. Bernardino L, Agasse F, Silva B, Ferreira R, Grade S, Malva JO. Tumor necrosis factor-alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures. Stem Cells 2008, 26:2361-2371. 10.1634/stemcells.2007-0914, 18583543.
42. Bento AR, Baptista S, Malva JO, Silva AP, Agasse F. Methamphetamine exerts toxic effects on subventricular zone stem/progenitor cells and inhibits neuronal differentiation. Rejuvenation Res 2011, 14:205-214. 10.1089/rej.2010.1109, 21453012.
43. Bernardino L, Xapelli S, Silva AP, Jakobsen B, Poulsen FR, Oliveira CR, Vezzani A, Malva JO, Zimmer J. Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J Neurosci 2005, 25:6734-6744. 10.1523/JNEUROSCI.1510-05.2005, 16033883.
44. Huang C, Ma R, Sun S, Wei G, Fang Y, Liu R, Li G. JAK2-STAT3 signaling pathway mediates thrombin-induced proinflammatory actions of microgliain vitro. J Neuroimmunol 2008, 204:118-125. 10.1016/j.jneuroim.2008.07.004, 18710787.
45. Kim OS, Park EJ, Joe EH, Jou I. JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J Biol Chem 2002, 277:40594-40601. 10.1074/jbc.M203885200, 12191995.
46. Gorina R, Sanfeliu C, Galito A, Messeguer A, Planas AM. Exposure of glia to pro-oxidant agents revealed selective Stat1 activation by H2O2 and Jak2-independent antioxidant features of the Jak2 inhibitor AG490. Glia 2007, 55:1313-1324. 10.1002/glia.20542, 17607690.
47. Baptista S, Bento AR, Goncalves J, Bernardino L, Summavielle T, Lobo A, Fontes-Ribeiro C, Malva JO, Agasse F, Silva AP. Neuropeptide Y promotes neurogenesis and protection against methamphetamine-induced toxicity in mouse dentate gyrus-derived neurosphere cultures. Neuropharmacology 2012, 62:2412-2422.
48. Hanisch UK. Microglia as a source and target of cytokines. Glia 2002, 40:140-155. 10.1002/glia.10161, 12379902.
49. De Vos J, Jourdan M, Tarte K, Jasmin C, Klein B. JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells. Br J Haematol 2000, 109:823-828. 10.1046/j.1365-2141.2000.02127.x, 10929036.
50. Deverman BE, Patterson PH. Cytokines and CNS development. Neuron 2009, 64:61-78. 10.1016/j.neuron.2009.09.002, 19840550.
51. Neta R, Sayers TJ, Oppenheim JJ. Relationship of TNF to interleukins. Immunol Ser 1992, 56:499-566.
52. Deng X, Cai NS, McCoy MT, Chen W, Trush MA, Cadet JL. Methamphetamine induces apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway. Neuropharmacology 2002, 42:837-845. 10.1016/S0028-3908(02)00034-5, 12015210.
53. Jayanthi S, Deng X, Bordelon M, McCoy MT, Cadet JL. Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex. FASEB J 2001, 15:1745-1752. 10.1096/fj.01-0025com, 11481222.
54. Dziennis S, Alkayed NJ. Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev Neurosci 2008, 19:341-361. 2681485, 19145989.
55. Cadet JL, Jayanthi S, Deng X. Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Review. Neurotox Res 2005, 8:199-206.
56. Harms AS, Lee JK, Nguyen TA, Chang J, Ruhn KM, Trevino I, Tansey MG. Regulation of microglia effector functions by tumor necrosis factor signaling. Glia 2012, 60:189-202. 10.1002/glia.21254, 21989628.
57. Yamashita A, Soga Y, Iwamoto Y, Yoshizawa S, Iwata H, Kokeguchi S, Takashiba S, Nishimura F. Macrophage-adipocyte interaction: marked interleukin-6 production by lipopolysaccharide. Obesity (Silver Spring) 2007, 15:2549-2552.
58. Inoue K, Koizumi S, Tsuda M, Shigemoto-Mogami Y. Signaling of ATP receptors in glia-neuron interaction and pain. Life Sci 2003, 74:189-197. 10.1016/j.lfs.2003.09.006, 14607246.
59. Marz P, Gadient RA, Otten U. Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-alpha). Brain Res 1996, 706:71-79. 10.1016/0006-8993(95)01210-9, 8720493.
60. Nakajima A, Yamada K, Nagai T, Uchiyama T, Miyamoto Y, Mamiya T, He J, Nitta A, Mizuno M, Tran MH, Seto A, Yoshimura M, Kitaichi K, Hasegawa T, Saito K, Yamada Y, Seishima M, Sekikawa K, Kim HC, Nabeshima T. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity. J Neurosci 2004, 24:2212-2225. 10.1523/JNEUROSCI.4847-03.2004, 14999072.
61. Yamada M, Hatanaka H. Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res 1994, 643:173-180. 10.1016/0006-8993(94)90023-X, 7913397.
62. Wang XC, Qiu YH, Peng YP. Interleukin-6 protects cerebellar granule neurons from NMDA-induced neurotoxicity. Sheng Li Xue Bao 2007, 59:150-156.
63. Wang XQ, Peng YP, Lu JH, Cao BB, Qiu YH. Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK. Neurosci Lett 2009, 450:122-126. 10.1016/j.neulet.2008.11.051, 19061939.
64. Haas CA, Hofmann HD, Kirsch M. Expression of CNTF/LIF-receptor components and activation of STAT3 signaling in axotomized facial motoneurons: evidence for a sequential postlesional function of the cytokines. J Neurobiol 1999, 41:559-571. 10.1002/(SICI)1097-4695(199912)41:4<559::AID-NEU11>3.0.CO;2-A, 10590179.
65. Hasegawa T, Suzuki K, Sakamoto C, Ohta K, Nishiki S, Hino M, Tatsumi N, Kitagawa S. Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia. Blood 2003, 101:1164-1171. 10.1182/blood-2002-05-1505, 12393423.
66. Cadet JL, Ordonez SV, Ordonez JV. Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2. Synapse 1997, 25:176-184. 10.1002/(SICI)1098-2396(199702)25:2<176::AID-SYN8>3.0.CO;2-9, 9021898.